{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T10:58:50Z","timestamp":1740135530308,"version":"3.37.3"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T00:00:00Z","timestamp":1592265600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T00:00:00Z","timestamp":1592265600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Hepatitis in young children with tuberculosis (TB) outside miliary TB is not well described and represents a challenge because of the hepatotoxicity associated with first-line anti-TB treatment.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Case presentation<\/jats:title>\n<jats:p>We report an antibiotic na\u00efve 13-month-old male from Nepal with pulmonary TB and hepatitis, who improved after TB treatment. We also performed a literature review for TB-associated hepatitis in children.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Liver function tests should be considered, when feasible, in infants and young children with pulmonary TB. Testing could help to identify and manage patients with TB-associated hepatic abnormalities, and also to establish a baseline for detection and management of liver injury associated with anti-TB therapy.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12890-020-01215-6","type":"journal-article","created":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T14:03:47Z","timestamp":1592316227000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Hepatitis in children with tuberculosis: a case report and review of the literature"],"prefix":"10.1186","volume":"20","author":[{"given":"Maria","family":"Sanchez-Codez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. Garret","family":"Hunt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua","family":"Watson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5983-8006","authenticated-orcid":false,"given":"Asuncion","family":"Mejias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,6,16]]},"reference":[{"key":"1215_CR1","unstructured":"Global Tuberculosis Report. Geneva: World Health Organization (WHO); 2019. License: CC BY-NC-SA 3.0 IGO. [Online]: https:\/\/www.who.int\/tb\/publications\/global_report\/en\/2018. Accessed Feb 2020."},{"issue":"12","key":"1215_CR2","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s11908-016-0546-5","volume":"18","author":"RP Evans","year":"2016","unstructured":"Evans RP, Mourad MM, Dvorkin L, Bramhall SR. Hepatic and intra-abdominal tuberculosis: 2016 update. Curr Infect Dis Rep. 2016;18(12):45. https:\/\/doi.org\/10.1007\/s11908-016-0546-5.","journal-title":"Curr Infect Dis Rep"},{"issue":"7","key":"1215_CR3","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1093\/cid\/ciw566","volume":"63","author":"P Nahid","year":"2016","unstructured":"Nahid P, Dorman SE, Alipanah N, Barry PM, Brozek JL, Cattamanchi A, et al. Executive summary: official American thoracic society\/centers for disease control and prevention\/infectious diseases society of America clinical practice guidelines: treatment of drug-susceptible tuberculosis. Clin Infect Dis. 2016;63(7):853\u201367. https:\/\/doi.org\/10.1093\/cid\/ciw566.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"1215_CR4","doi-asserted-by":"publisher","first-page":"247","DOI":"10.4066\/AMJ.2014.2076","volume":"7","author":"M Shastri","year":"2014","unstructured":"Shastri M, Kausadikar S, Jariwala J, Dave D, Patell R. Isolated hepatic tuberculosis: an uncommon presentation of a common culprit. Australas Med J. 2014;7(6):247\u201350. https:\/\/doi.org\/10.4066\/AMJ.2014.2076.","journal-title":"Australas Med J"},{"issue":"RR-11","key":"1215_CR5","first-page":"1","volume":"52","author":"American Thoracic S, Cdc, Infectious Diseases Society of A","year":"2003","unstructured":"American Thoracic S, Cdc, Infectious Diseases Society of A. Treatment of tuberculosis. MMWR Recomm Rep. 2003;52(RR-11):1\u201377.","journal-title":"MMWR Recomm Rep"},{"issue":"3","key":"1215_CR6","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1179\/2046905512Y.0000000033","volume":"33","author":"D Nandan","year":"2013","unstructured":"Nandan D, Bhatt GC, Dewan V, Yadav TP, Singh S. Isolated tuberculous liver abscess in a 3-year-old immunocompetent child. Paediatr Int Child Health. 2013;33(3):187\u20139. https:\/\/doi.org\/10.1179\/2046905512Y.0000000033.","journal-title":"Paediatr Int Child Health"},{"issue":"1","key":"1215_CR7","doi-asserted-by":"publisher","first-page":"162","DOI":"10.4269\/ajtmh.2012.11-0643","volume":"87","author":"M Mojtahedzadeh","year":"2012","unstructured":"Mojtahedzadeh M, Otoukesh S, Shahsafi MR, Tahbaz MO, Rahvari SK, Poorabdollah M, et al. Case report: portal hypertension secondary to isolated liver tuberculosis. Am J Trop Med Hyg. 2012;87(1):162\u20134. https:\/\/doi.org\/10.4269\/ajtmh.2012.11-0643.","journal-title":"Am J Trop Med Hyg"},{"key":"1215_CR8","doi-asserted-by":"publisher","first-page":"5318197","DOI":"10.1155\/2018\/5318197","volume":"2018","author":"R Al Umairi","year":"2018","unstructured":"Al Umairi R, Al Abri A, Kamona A. Tuberculosis (TB) of the porta hepatis presenting with obstructive jaundice mimicking a malignant biliary tumor: a case report and review of the literature. Case Rep Radiol. 2018;2018:5318197. https:\/\/doi.org\/10.1155\/2018\/5318197.","journal-title":"Case Rep Radiol"},{"key":"1215_CR9","doi-asserted-by":"publisher","unstructured":"Kandasamy S, Govindarajalou R, Chakkalakkoombil SV, Penumadu P. Isolated hepatobiliary tuberculosis: a diagnostic challenge. BMJ Case Rep. 2018;2018. https:\/\/doi.org\/10.1136\/bcr-2017-223912.","DOI":"10.1136\/bcr-2017-223912"},{"issue":"8","key":"1215_CR10","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1164\/rccm.200510-1666ST","volume":"174","author":"JJ Saukkonen","year":"2006","unstructured":"Saukkonen JJ, Cohn DL, Jasmer RM, Schenker S, Jereb JA, Nolan CM, et al. An official ATS statement: hepatotoxicity of antituberculosis therapy. Am J Respir Crit Care Med. 2006;174(8):935\u201352. https:\/\/doi.org\/10.1164\/rccm.200510-1666ST.","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"1215_CR11","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1067\/mcp.2002.126175","volume":"72","author":"K Ohkawa","year":"2002","unstructured":"Ohkawa K, Hashiguchi M, Ohno K, Kiuchi C, Takahashi S, Kondo S, et al. Risk factors for antituberculous chemotherapy-induced hepatotoxicity in Japanese pediatric patients. Clin Pharmacol Ther. 2002;72(2):220\u20136. https:\/\/doi.org\/10.1067\/mcp.2002.126175.","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"1215_CR12","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1097\/00006454-198505000-00013","volume":"4","author":"H Tsagaropoulou-Stinga","year":"1985","unstructured":"Tsagaropoulou-Stinga H, Mataki-Emmanouilidou T, Karida-Kavalioti S, Manios S. Hepatotoxic reactions in children with severe tuberculosis treated with isoniazid-rifampin. Pediatr Infect Dis. 1985;4(3):270\u20133. https:\/\/doi.org\/10.1097\/00006454-198505000-00013.","journal-title":"Pediatr Infect Dis"},{"issue":"2","key":"1215_CR13","doi-asserted-by":"publisher","DOI":"10.4081\/pr.2011.e16","volume":"3","author":"PR Donald","year":"2011","unstructured":"Donald PR. Antituberculosis drug-induced hepatotoxicity in children. Pediatr Rep. 2011;3(2):e16. https:\/\/doi.org\/10.4081\/pr.2011.e16.","journal-title":"Pediatr Rep"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-020-01215-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-020-01215-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-020-01215-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,15]],"date-time":"2021-06-15T23:08:02Z","timestamp":1623798482000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-020-01215-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,16]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1215"],"URL":"https:\/\/doi.org\/10.1186\/s12890-020-01215-6","relation":{},"ISSN":["1471-2466"],"issn-type":[{"type":"electronic","value":"1471-2466"}],"subject":[],"published":{"date-parts":[[2020,6,16]]},"assertion":[{"value":"28 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article summarizes the clinical presentation of a single patient for which Nationwide Children\u2019s Institutional Review Board (IRB) does not require ethical approval. Nevertheless, written informed consent to publish the personal and clinical details of the patient included in the manuscript was obtained from legal guardians.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent to publish the personal and clinical details of the child included in this report was obtained from caregiver following BMC guidelines. No identifying images have been included in this report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"173"}}